Marea Therapeutics
Clinical trials sponsored by Marea Therapeutics, explained in plain language.
-
New drug trial targets dangerous After-Meal fat spikes
Disease control Recruiting nowThis study is testing whether an experimental drug called MAR001 can lower unhealthy fat levels in the blood after meals. Researchers will compare MAR001 against a placebo in 30 adults who have high triglycerides. Participants will take the study drug and then have their blood fa…
Phase: PHASE2 • Sponsor: Marea Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
First human test of new acromegaly drug begins
Knowledge-focused Recruiting nowThis is the first study testing a new drug called MAR002 in humans. Researchers will give the drug to 45 healthy men to check if it's safe and see how the body processes it. The goal is to gather early information before testing in people with acromegaly, a hormonal disorder.
Phase: PHASE1 • Sponsor: Marea Therapeutics • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC